RetractedArticlePloS one2013

Epithelial-mesenchymal transition markers and HER3 expression are predictors of elisidepsin treatment response in breast and pancreatic cancer cell lines.

Cristina Teixidó et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.